HALOZYME THERAPEUTICS: all contributions
2023–2024 · Reported individual contributions grouped by employer.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to HALOZYME THERAPEUTICS| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↑ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 1 | CANNON, KERISAN DIEGOCA92126 | SCIENTISTHALOZYME THERAPEUTICS | HARRIS FOR PRESIDENTC00703975 | 2024-10-21 | $25 | General 2024 (G2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1890563 · amendedFEC filing ↗ |
| 2 | KNOWLES, STEPHENSAN DIEGOCA92103 | CHIEF MEDICAL OFFICERHALOZYME THERAPEUTICS | HARRIS FOR PRESIDENTC00703975 | 2024-08-30 | $25 | General 2024 (G2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1817925FEC filing ↗ |
| 3 | KNOWLES, STEPHENSAN DIEGOCA92103 | CHIEF MEDICAL OFFICERHALOZYME THERAPEUTICS | HARRIS FOR PRESIDENTC00703975 | 2024-07-30 | $25 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1832056 · amendedFEC filing ↗ |
| 4 | KNOWLES, STEPHENSAN DIEGOCA92103 | CHIEF MEDICAL OFFICERHALOZYME THERAPEUTICS | HARRIS FOR PRESIDENTC00703975 | 2024-09-30 | $25 | General 2024 (G2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1833711FEC filing ↗ |
| 5 | CANNON, KERISAN DIEGOCA92126 | SCIENTISTHALOZYME THERAPEUTICS | HARRIS FOR PRESIDENTC00703975 | 2024-10-29 | $50 | General 2024 (G2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1890563 · amendedFEC filing ↗ |
| 6 | CANNON, KERISAN DIEGOCA92126 | SCIENTISTHALOZYME THERAPEUTICS | HARRIS FOR PRESIDENTC00703975 | 2024-10-08 | $50 | General 2024 (G2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1890549 · amendedFEC filing ↗ |
| 7 | CANNON, KERISAN DIEGOCA92126 | SCIENTISTHALOZYME THERAPEUTICS | HARRIS FOR PRESIDENTC00703975 | 2024-11-05 | $50 | General 2024 (G2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1890563 · amendedFEC filing ↗ |
| 8 | CANNON, KERISAN DIEGOCA92126 | SCIENTISTHALOZYME THERAPEUTICS | HARRIS FOR PRESIDENTC00703975 | 2024-10-15 | $50 | General 2024 (G2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1890549 · amendedFEC filing ↗ |
| 9 | CANNON, KERISAN DIEGOCA92126 | SCIENTISTHALOZYME THERAPEUTICS | HARRIS FOR PRESIDENTC00703975 | 2024-10-22 | $50 | General 2024 (G2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1890563 · amendedFEC filing ↗ |
| 10 | CANNON, KERISAN DIEGOCA92126 | SCIENTISTHALOZYME THERAPEUTICS | HARRIS FOR PRESIDENTC00703975 | 2024-10-01 | $50 | General 2024 (G2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1890549 · amendedFEC filing ↗ |
| 11 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | ACTBLUEC00401224 | 2023-12-29 | $200 | Not reported | EARMARKED FOR SUMMER LEE FOR CONGRESS (C00791780)Filing 1752852FEC filing ↗ |
| 12 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | ACTBLUEC00401224 | 2023-12-01 | $250 | Not reported | EARMARKED FOR PRAMILA FOR CONGRESS (C00605592)Filing 1752852FEC filing ↗ |
| 13 | GRANT, CAROLYNNCARLSBADCA92008 | ASSOC DIRECTORHALOZYME THERAPEUTICS | FAIR FIGHTC00693515 | 2024-08-24 | $250 | Primary (P) | NON-CONTRIBUTION ACCOUNTFiling 1839963 · amendedFEC filing ↗ |
| 14 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | PRAMILA FOR CONGRESSC00605592 | 2023-12-01 | $250 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1748303FEC filing ↗ |
| 15 | GRANT, CAROLYNNCARLSBADCA92008 | ASSOC DIRECTORHALOZYME THERAPEUTICS | FAIR FIGHTC00693515 | 2024-10-14 | $250 | Primary (P) | NON-CONTRIBUTION ACCOUNTFiling 1840041FEC filing ↗ |
| 16 | GRANT, CAROLYNNCARLSBADCA92008 | ASSOC. DIRECTORHALOZYME THERAPEUTICS | HARRIS FOR PRESIDENTC00703975 | 2024-10-23 | $250 | General 2024 (G2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1890563 · amendedFEC filing ↗ |
| 17 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | ACTBLUEC00401224 | 2024-01-27 | $500 | Primary (P) | EARMARKED FOR BARBARA LEE FOR U.S. SENATE (C00833608)Filing 1758569FEC filing ↗ |
| 18 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | COMMITTEE TO ELECT NASSER BEYDOUNC00837112 | 2024-02-01 | $500 | Primary 2024 (P2024) | Filing 1799742 · amendedFEC filing ↗ |
| 19 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | BOWMAN FOR CONGRESSC00709196 | 2024-02-04 | $500 | Primary 2024 (P2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1802917 · amendedFEC filing ↗ |
| 20 | QADAN, AMMARSAN DIEGOCA92130 | MARKETINGHALOZYME THERAPEUTICS | LATEEFAH FOR CONGRESSC00834291 | 2024-10-20 | $500 | General 2024 (G2024) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1855854FEC filing ↗ |
This small employer group is read directly through the employer index, then sorted and paginated. Only the latest version within matching employer records is shown; amendments that change the employer may affect this grouping. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.